Brief: CTI Biopharma Enrolls First Patient In Covid-19 Pre-Vent Phase 3 Trial

CTI Biopharma

01/06/2020 12:13

June 1 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA ANNOUNCES ENROLLMENT OF FIRST PATIENT IN
COVID-19
PRE-VENT PHASE 3 CLINICAL TRIAL
    * COMPANY EXPECTS TO REPORT TOPLINE DATA BY END OF 2020
    * CTI BIOPHARMA-PRE-VENT TO COMPARE PACRITINIB PLUS STANDARD
OF
CARE VERSUS PLACEBO & STANDARD OF CARE IN 358 HOSPITALIZED
PATIENTS WITH SEVERE COVID-19

Source text for Eikon:  ID:nPn1YG76ma 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))